// App-Quantinova.ai

3776 : Mechanistic evaluation of AG311 - an OXPHOS inhibitor - as a potential treatment for breast cancer

Researchers

Presenter

  • Anja Bastian

Principal Investigators

  • Satoshi Matsuzaki

  • Kenneth M. Humphries

  • Lora C. Bailey-Downs

  • Aleem Gangjee

  • Michael A. Ihnat

Medical Centers

  • University of Oklahoma Health Sciences Center, Oklahoma City, OK

  • Oklahoma Medical Research Foundation, Oklahoma city, OK.

  • Duquesne University, Pittsburgh, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

  • Breast cancer

  • Solid malignancies

  • Tuberculosis

Biomarkers

  • N/A

Drug/Treatment

  • Dichloroacetate

  • thiocoraline

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved